University of Miami
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Miami sits in the top decile of US sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count).
University of Miami: 721 sponsored US clinical trials, 145 recruiting.
University of Miami sponsors 721 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 430 completed. 79 of these trials are in Phase 3-4 (later-stage) and 134 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 10 trials.
Top-decile sponsor footprint
University of Miami ranks in the top decile of sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
430 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
721 total, page 3 of 15
NSAID Use After Robotic Partial Nephrectomy
NCT05842044
Integrated Navigation Services for Treatment Adherence, Counseling, and Research
NCT04663152
The Use of Functional Electrical Stimulation in Conjunction With Respiratory Muscle Training to Improve Unaided Cough in Individuals With Acute Spinal Cord Injury
NCT05745298
Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer
NCT05959291
Physical Activity in Hidradenitis Suppurativa (HS)
NCT06015438
Lifestyle Intervention of Food and Exercise for Lymphoma Survivors
NCT05839210
Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPD
NCT05607719
Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma
NCT05530421
Combating Alzheimer's Through Sleep and Exercise
NCT04855630
Association Between Body Composition and Pain in Spinal Cord Injury
NCT05459207
SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer
NCT05412082
Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma
NCT05284643
Sensors Prediction Study
NCT04541992
Early Detection of Vaping-related Vascular Diseases
NCT05454267
Comprehensive Behavioral Intervention for Tics
NCT05370391
Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
NCT05296070
Metabolism and Sleep Apnea Treatment
NCT05539716
An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS
NCT03738410
Mental Health in Primary Care
NCT05426057
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions
NCT05361694
The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIV
NCT05453513
Evaluation of Grief Therapy Approaches for Bereaved Parents
NCT05142605
Prospective Evaluation of Targeted Axillary Dissection (TAD)
NCT04998682
Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms
NCT04141020
Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences
NCT04650256
Cultural Adaptation of a SSI for Youth Anxiety
NCT04729504
PAP for Children With DS and OSAS
NCT04132999
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
NCT04295486
Opioid, HIV and Immune System
NCT04304768
Tfh Dysfunction in HIV and Aging
NCT04487041
SABER Study for Selected Early Stage Breast Cancer
NCT04360330
The EBC Recovery Study
NCT04712591
Non-invasive Glioma Characterization Through Molecular Imaging
NCT03684109
Natural Helpers and PCIT
NCT05400434
Clinical Procedures to Support Research in ALS
NCT03489278
Systemic Hypothermia in Acute Cervical Spinal Cord Injury
NCT02991690
Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients
NCT02997709
Immune Reconstitution in Stem Cell Transplant Recipients
NCT02129543
BLOOM: Biological Legacy of Origin in Mother-Infant Dyads
NCT02000895
Proteinuria in Pre and Post Transplant
NCT01094327
Clinical Applications of Advanced Ophthalmic Imaging
NCT03135327
The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study
NCT00317616
Type 1 Diabetes Recurrence in Pancreas Transplants
NCT01047865
Clinical Research in ALS Study
NCT00136500
Male Fertility Program
NCT01467869
Nutrition and Pain Study
NCT07179588
Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA)
NCT07006714
The Use of Cyproheptadine in Pediatric Feeding Disorders
NCT06751290
Digital Health Intervention to Promote Quality of Life in Adults With Chronic Graft Versus Host Disease
NCT06688942
Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2
NCT07224048
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 48 |
| Phase 2 | 86 |
| Phase 3 | 18 |
| Phase 4 | 61 |
Therapeutic Areas
What is open in the University of Miami pipeline
145 recruiting of 721 indexed (20% open); 430 completed (60%).
Phase mix: 79 late (III/IV) vs 134 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Miami: open-pipeline peers nationwide
Peers matched on 721 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of Miami sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 721 trials (± recruiting share)
- Sanofi · 713 trials · 10% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
Sponsors near 20% open enrollment (± trial volume)
- University of California, Irvine · 20% recruiting · 368 trials
- Endeavor Health · 20% recruiting · 94 trials
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
Related
What to do with this University of Miami page
721 registered trials is a research-attention snapshot, not an endorsement of University of Miami or any single study.
- 145 of University of Miami's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition University of Miami studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Miami pipeline card: 721 registered trials from official public datasets.Report a data error.